A patient is to receive hormone therapy as adjunct treatment for ...

[audie]

A patient is to receive hormone therapy as adjunct treatment for advanced breast cancer. The nurse should anticipate that the primary care provider will choose which oral medication for this patient?
 
  1. trastuzumab (Herceptin)
  2. bevacizumab (Avastin)
  3. goserelin (Zoladex)
  4. fulvestrant (Faslodex)

Question 2

The nurse is caring for a patient who will be receiving radiation therapy for cervical cancer. Patient education should include which skin care interventions?
 
  Select all that apply.
  1. wound and skin care
  2. applying oil-based lotions to the skin
  3. how to remove the markings from the skin
  4. monitoring for evidence of fistula formation
  5. applying heat to the abdomen with a heating pad

[mfedorka]

Answer to Question 1

Correct Answer: 2
Bevacizumab (Avastin) is an oral drug that targets the HER2 protein. Trastuzumab (Herceptin) is an IV immunotherapy drug that stops the growth of breast tumors. The gonadotropin-releasing hormone agonist (GnRH-a) goserelin (Zoladex) is used to treat endometrial cancer. Fulvestrant (Faslodex) eliminates estrogen receptors and is given by injection once a month.

Answer to Question 2

Correct Answer: 1, 4
Wound and skin care is important to prevent or minimize skin breakdown associated with radiation therapy. Fistula formation is a potential complication of radiation to the pelvic or abdominal cavities. Fistulas may develop between the vagina and bladder or rectum. Patients should apply nonoil-based lotions to the skin to relieve itching and maintain skin integrity. Markings are used to localize the radiation beam to the target area and are essential for future radiation treatments. Use of a heating pad to reduce pain is recommended in care for endometrial cancer.